Retractable Technologies
RVPRetractable Technologies, Inc. designs, manufactures, and markets safety-engineered medical products, primarily focused on syringes and needles for the healthcare industry.
Table of contents
Earnings
Next report
Date not yet announcedCompetitors
By market cap
By revenue growth
Profile
Retractable Technologies, Inc. designs, manufactures, and markets safety-engineered medical products, primarily focused on syringes and needles for the healthcare industry. The company's core value proposition centers on protecting healthcare workers and patients from needlestick injuries and cross-contamination through patented automated retraction technology. Its products are widely utilized in clinical settings and mass vaccination efforts, offering safety features that activate while the needle is still in the patient.
A specialized safety technology provider competing against significantly larger global medical supply corporations through patented innovation and domestic manufacturing capabilities.
Questions, answered.
- What is Retractable Technologies's market cap?
- Retractable Technologies (RVP) has a market capitalization of $20.1M and trades on AMEX.
- Who are Retractable Technologies's competitors?
- Retractable Technologies's key competitors include Embecta Corp., Becton, Dickinson and Company, Cardinal Health, Inc., and others. These companies compete in similar markets and product categories.
- Who does Retractable Technologies partner with?
- Retractable Technologies's notable partners include U.S. Department of Defense, Biomedical Advanced Research and Development Authority.
- Where is Retractable Technologies headquartered?
- Retractable Technologies is headquartered in United States of America and employs approximately 151 people. It has been publicly traded since 2001.